How to cite item

Prolyl hydroxylase domain inhibitors: a new era in the management of renal anemia

   
@article{ATM30328,
	author = {Yu Kurata and Tetsuhiro Tanaka and Masaomi Nangaku},
	title = {Prolyl hydroxylase domain inhibitors: a new era in the management of renal anemia},
	journal = {Annals of Translational Medicine},
	volume = {7},
	number = {Suppl 8},
	year = {2019},
	keywords = {},
	abstract = {Prolyl hydroxylase domain (PHD) inhibitors are orally bioavailable small-molecule compounds that activate hypoxia inducible factor (HIF). HIF is a master transcription factor for regulating the cellular adaptive response to hypoxia. Erythropoietin (EPO), a hormone essential for red blood cell production, is one of the target genes of HIF. PHD inhibitors have been developed for the treatment of anemia with chronic kidney disease (CKD).},
	issn = {2305-5847},	url = {https://atm.amegroups.org/article/view/30328}
}